OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy
Maria Chiara Pismataro, Andrea Astolfi, Maria Letizia Barreca, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6498-6522
Open Access | Times Cited: 25
Maria Chiara Pismataro, Andrea Astolfi, Maria Letizia Barreca, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6498-6522
Open Access | Times Cited: 25
Showing 25 citing articles:
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 17
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 17
Helicases in R-loop Formation and Resolution
Shizhuo Yang, Lacey Winstone, Sohaumn Mondal, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105307-105307
Open Access | Times Cited: 32
Shizhuo Yang, Lacey Winstone, Sohaumn Mondal, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105307-105307
Open Access | Times Cited: 32
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
Yvette Drew, Frank T. Zenke, Nicola J. Curtin
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 19-39
Closed Access | Times Cited: 12
Yvette Drew, Frank T. Zenke, Nicola J. Curtin
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 19-39
Closed Access | Times Cited: 12
Discovery and Proof of Concept of Potent Dual Polθ/PARP Inhibitors for Efficient Treatment of Homologous Recombination-Deficient Tumors
Luyu Ma, Wei Chen, Ming Yang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3606-3625
Closed Access | Times Cited: 6
Luyu Ma, Wei Chen, Ming Yang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3606-3625
Closed Access | Times Cited: 6
Role of Translesion DNA Synthesis in the Metabolism of Replication-associated Nascent Strand Gaps
Jude B. Khatib, Claudia M. Nicolae, George‐Lucian Moldovan
Journal of Molecular Biology (2023) Vol. 436, Iss. 1, pp. 168275-168275
Closed Access | Times Cited: 15
Jude B. Khatib, Claudia M. Nicolae, George‐Lucian Moldovan
Journal of Molecular Biology (2023) Vol. 436, Iss. 1, pp. 168275-168275
Closed Access | Times Cited: 15
DNA-PKcs suppresses illegitimate chromosome rearrangements
Jinglong Wang, Cheyenne Sadeghi, Richard L. Frock
Nucleic Acids Research (2024) Vol. 52, Iss. 9, pp. 5048-5066
Open Access | Times Cited: 5
Jinglong Wang, Cheyenne Sadeghi, Richard L. Frock
Nucleic Acids Research (2024) Vol. 52, Iss. 9, pp. 5048-5066
Open Access | Times Cited: 5
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors
Shaobin Wang, Chao Wang, Jinxin Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117662-117662
Closed Access | Times Cited: 4
Shaobin Wang, Chao Wang, Jinxin Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117662-117662
Closed Access | Times Cited: 4
Targeting the DNA damage response in cancer
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
Structural basis of error-prone DNA synthesis by DNA polymerase θ
Chuxuan Li, Leora Maksoud, Yang Gao
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Chuxuan Li, Leora Maksoud, Yang Gao
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Anemarchalconyn, a natural alkyne ketone compound, inhibits HCC cell growth by suppressing Polθ and inducing synthetic lethality in Homologous recombination deficiency cells
Junnan Li, Wenwen Deng, Tong Zhou, et al.
Phytomedicine (2025), pp. 156679-156679
Closed Access
Junnan Li, Wenwen Deng, Tong Zhou, et al.
Phytomedicine (2025), pp. 156679-156679
Closed Access
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors
Tancredi Didier Bazan Russo, Clarissa Mujacic, Emilia Di Giovanni, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1619-1631
Open Access | Times Cited: 3
Tancredi Didier Bazan Russo, Clarissa Mujacic, Emilia Di Giovanni, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 11, pp. 1619-1631
Open Access | Times Cited: 3
Research Progress in DNA Damage Response (DDR)-Targeting Modulators: from Hits to Clinical Candidates
Binbin Cheng, Zongbao Ding, Yun Hong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117347-117347
Closed Access
Binbin Cheng, Zongbao Ding, Yun Hong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117347-117347
Closed Access
Polymerase Ѳ Inhibitors Combinations with Approved and Investigational Agents in Patient-Derived Tumor Multi-Cell Type (Mct) Spheroids
Beverly Ann Teicher, Thomas S. Dexheimer, Li Chen, et al.
(2025)
Closed Access
Beverly Ann Teicher, Thomas S. Dexheimer, Li Chen, et al.
(2025)
Closed Access
Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges
Shixuan Peng, M.D. Long, Qi-Sheng Chen, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Shixuan Peng, M.D. Long, Qi-Sheng Chen, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Design and discovery of POLQ helicase domain inhibitors by virtual screening and machine learning
Wei Feng, Lei Liu, Lingjun Li, et al.
Medicinal Chemistry Research (2025)
Closed Access
Wei Feng, Lei Liu, Lingjun Li, et al.
Medicinal Chemistry Research (2025)
Closed Access
KDM4B mutations in human cancers
Wesley Bush, Korey Bosart, Renee A. Bouley, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 829, pp. 111866-111866
Open Access | Times Cited: 2
Wesley Bush, Korey Bosart, Renee A. Bouley, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 829, pp. 111866-111866
Open Access | Times Cited: 2
An update on small molecule compounds targeting synthetic lethality for cancer therapy
Jiaxiang Luo, Yang Li, Yiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116804-116804
Closed Access | Times Cited: 2
Jiaxiang Luo, Yang Li, Yiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116804-116804
Closed Access | Times Cited: 2
Inhibitors against DNA Polymerase I Family of Enzymes: Novel Targets and Opportunities
Saathvik R. Kannan, Samuel W. Gillespie, Wendy L. Picking, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 204-204
Open Access | Times Cited: 1
Saathvik R. Kannan, Samuel W. Gillespie, Wendy L. Picking, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 204-204
Open Access | Times Cited: 1
Where Do We Stand in Targeted Therapy Against BRCA1/2 Deficient Cancers?
Zoe Manuel-Epstein
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2024) Vol. 8, Iss. 8, pp. 1-11
Open Access | Times Cited: 1
Zoe Manuel-Epstein
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2024) Vol. 8, Iss. 8, pp. 1-11
Open Access | Times Cited: 1
DNA-PKcs Suppresses Illegitimate Chromosome Rearrangements
Jinglong Wang, Cheyenne Sadeghi, Richard L. Frock
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Jinglong Wang, Cheyenne Sadeghi, Richard L. Frock
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cold Physical Plasma-Mediated Fenretinide Prodrug Activation Confers Additive Cytotoxicity in Epithelial Cells
Mohsen Ahmadi, Debora Singer, Felix Potlitz, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1271-1271
Open Access | Times Cited: 3
Mohsen Ahmadi, Debora Singer, Felix Potlitz, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1271-1271
Open Access | Times Cited: 3
ATM and 53BP1 regulate alternative end joining–mediated V(D)J recombination
Jinglong Wang, Cheyenne Sadeghi, Long V. Le, et al.
Science Advances (2024) Vol. 10, Iss. 31
Open Access
Jinglong Wang, Cheyenne Sadeghi, Long V. Le, et al.
Science Advances (2024) Vol. 10, Iss. 31
Open Access
Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells
Gabriela Barszczewska-Pietraszek, Piotr Czarny, Małgorzata Drzewiecka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9134-9134
Open Access
Gabriela Barszczewska-Pietraszek, Piotr Czarny, Małgorzata Drzewiecka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9134-9134
Open Access
Quinoline-based compounds can inhibit diverse enzymes that act on DNA
Jujun Zhou, Qin Chen, Ren Ren, et al.
Cell chemical biology (2024)
Open Access
Jujun Zhou, Qin Chen, Ren Ren, et al.
Cell chemical biology (2024)
Open Access
Cryo-EM structures of the Plasmodium falciparum apicoplast DNA polymerase
Chen‐Yu Lo, Adron Robert Ung, Tirthankar Koley, et al.
Journal of Molecular Biology (2024), pp. 168842-168842
Closed Access
Chen‐Yu Lo, Adron Robert Ung, Tirthankar Koley, et al.
Journal of Molecular Biology (2024), pp. 168842-168842
Closed Access
